RM
Insider
Ross Moat
CHIEF OPERATING OFFICERRoss Moat (CHIEF OPERATING OFFICER) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Kiniksa Pharmaceuticals International, plc (KNSA). The largest single filing was $115K of KNSA (2,367 sh × $48.58, as filed), executed Apr 6.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$115K
shares × price, as filed
Last traded
Apr 6
Filed Apr 8
Median ADV $60.8M across their filed names
Open performance→Volume by month
Buys $0
Sells $4.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
KNSARecent filings
KNSASALE
Kiniksa Pharmaceuticals International, plc
View filing →
$115K2,367 sh × $48.58
Exec Apr 6
Filed Apr 8 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $124K
3,523 sh × $35.31
Exec Sep 4 2025
Filed Sep 8 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $801K
27,594 sh × $29.02
Exec Jun 3 2025
Filed Jun 5 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $283K
10,122 sh across 2 lots
Exec May 2 2025
Filed May 5 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $2.3M
87,269 sh across 2 lots
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET KNSASALE Kiniksa Pharmaceuticals International, plc View filing → $370K
18,259 sh × $20.29
Exec Apr 21 2025
Filed Apr 23 2025 · 5:30 PM ET